|
|
| (11) | Number of the document | C 3808743 |
| (68) | Number of the document | 3808743 |
| (21) | Application number for Supplementary Protection Certificate | PA 2022 515 |
| (22) | Date of filing the application | 2022-08-02 |
| (41) | Date of publication of the application | 2022-08-25 |
| Date of publication of SPC | 2023-04-25 | |
| (24) | Date of coming into effect of SPC | 2022-08-10 |
| (71) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/11/737/001-002, 2011-11-28 |
| (94) | 2026-11-28 |
| (95) | Rilpivirino arba farmaciniu požiūriu priimtinos pridėtinės rilpivirino druskos, įskaitant rilpivirino hidrochlorido rūgšties druską, ir emtricitabino derinys |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 4 | 347.00 EUR |
| 2026-08-10 |
| SPC granted |